Patents Examined by Raymond J. Henley, II
  • Patent number: 7192951
    Abstract: Combinations of diuretics and vasopressin antagonists are useful to slow and reverse the symptoms and process of congestive heart failure, to increase the excretion of water in the urine, and to decrease the excretion of sodium and potassium ions in urine. Preferred vasopressin antagonists have the formula wherein R and R5 are hydrogen or lower alkyl; R1, R2, and R3 are hydrogen, halo, alkyl, alkoxy, and amino; and R4 is hydrogen or phenyl, and a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 16, 2005
    Date of Patent: March 20, 2007
    Assignee: Astellas Pharma Inc.
    Inventors: Rebecca Guggemos Bakker-Arkema, Milton Lethan Pressler
  • Patent number: 5087624
    Abstract: The administration of chromic picolinate, preferably in the form of chromic tripicolinate, as a prophylactic or therapeutic agent for controlling various blood serum parameters. In particular, the administration is for controlling blood serum lipid levels, including the lowering of undesirably high blood serum LDL-cholesterol levels and the raising of blood serum HDL-cholesterol levels. Additionally, the administration is for controlling undesirable high blood serum glucose levels, this being particularly applicable for the treatment of maturity-onset diabetes. Additionally, chromic picolinate, preferably in the form of chromic tripicolinate, is administered to facilitate uptake of amino acids by skeletal muscle. Thus chromic picolinate can act as an effective anabolic agent.
    Type: Grant
    Filed: July 13, 1990
    Date of Patent: February 11, 1992
    Assignee: Nutrition 21
    Inventors: Herb Boynton, Gary W. Evans
  • Patent number: 5080908
    Abstract: A vitamin B.sub.12 composition wherein vitamin B.sub.12 exists as dispersed in a mixture of starch and dextrin can keep vitamin B.sub.12 stable for a long time and can be easily manufactured by the ordinary convenient method without employing any special equipment.
    Type: Grant
    Filed: August 28, 1990
    Date of Patent: January 14, 1992
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Yasuo Ono, Kunihiko Sumimura, Junzou Yamashita
  • Patent number: 5021570
    Abstract: An aqueous solution containing fat-soluble vitamin K is prepared by adding vegetable oil(s), gycerol fatty acid ester(s) or sorbitan fatty acid ester(s) in an amount of 0.004 to 5% by weight, based on the whole aqueous solution, to an aqueous solution containing menatetrenone (vitamin K.sub.2) or phytonadione (vitamin K.sub.1) and hydrogenated lecithin.
    Type: Grant
    Filed: July 7, 1989
    Date of Patent: June 4, 1991
    Assignee: Eisai Co., Ltd.
    Inventors: Katsumi Ida, Takayuki Ikeuchi, Masanori Kayano
  • Patent number: 4889954
    Abstract: Tertiary amines are converted to amine oxides in high conversion and at a faster rate by including dialkylcarbonate in the reaction of the tert-amine with aqueous hydrogen peroxide. Ascorbic acid can be used as a co-catalyst.
    Type: Grant
    Filed: June 30, 1988
    Date of Patent: December 26, 1989
    Assignee: Ethyl Corporation
    Inventors: Kathleen S. Laurenzo, Dennis P. Bauer
  • Patent number: 4874603
    Abstract: Blood coagulation can be normalized in persons consuming high saturated fatty acids of omega-3 type, such as eicosapentanoic acid and docosahexanoic acid, by administration of vitamin E in an amount between about 40% to 100% by weight of the fatty acid(s). An article of manufacture is thus provided comprising such fatty acids and vitamin E.
    Type: Grant
    Filed: March 15, 1988
    Date of Patent: October 17, 1989
    Inventor: Uwe Fratzer